Concepedia

Marie‐Emmanuelle Riviere

MR

7

Publications

415

Citations

7

H-Index

2001

Active since

Affiliations

Novartis (Switzerland)(Current)

Banner Alzheimer’s Institute

Alzheimer's Association

Novartis (United States)

Tris Pharma (United States)

Marie‐Emmanuelle Riviere is an author at Novartis (Switzerland) specializing in medicine, neurology, and neurodegenerative diseases.

Top concepts

Publications per year

2001–2024

7

Publications

7

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study

Rik Vandenberghe, Marie‐Emmanuelle Riviere, Angelika Caputo et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 133 citations · Full text

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

Sven Pålhagen, R. Canger, Olaf Henriksen et al. · Epilepsy Research · 2001 · 127 citations

, , +5

Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials

Carolyn Langlois, Angela R. Bradbury, Elisabeth McCarty Wood et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 49 citations · Full text

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

Jessica B. Langbaum, Noel Ellison, Angelika Caputo et al. · Alzheimer s Research & Therapy · 2020 · 36 citations · Full text

THE ALZHEIMER’S PREVENTION INITIATIVE GENERATION PROGRAM: EVALUATING CNP520 EFFICACY IN THE PREVENTION OF ALZHEIMER’S DISEASE

Cristina López López, Antonella Caputo, F. Liu et al. · The Journal of Prevention of Alzheimer s Disease · 2017 · 35 citations · Full text

, , +7

Rows per page

1–5 of 7